![Rhian Jones](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Rhian Jones active positions
Companies | Position | Start | End |
---|---|---|---|
Drive
![]() Drive Miscellaneous Commercial ServicesCommercial Services Drive is a non-profit LLC that focuses on discovering and developing antiviral drugs for emerging infections, pandemic threats, and biodefense. The non-profit company is based in Nantgarw, UK. The British company operates like an early stage biotechnology company and applies focus and industry development expertise to efficiently translate discoveries to address viruses of concern. The company is unique in that it brings industry expertise to the assets of a leading research university to develop potential antiviral drugs to a de-risked value inflection point that substantially increases the probability of the potential drug being licensed by industry and developed for the ultimate benefit of the public. The company was founded in 1983. Rhian Jones has been the CEO of the company since 2018. | Chief Executive Officer | 2018-09-17 | - |
Career history of Rhian Jones
Statistics
International
United Kingdom | 2 |
Operational
Chief Executive Officer | 1 |
Sectoral
Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 1 |
---|---|
Drive
![]() Drive Miscellaneous Commercial ServicesCommercial Services Drive is a non-profit LLC that focuses on discovering and developing antiviral drugs for emerging infections, pandemic threats, and biodefense. The non-profit company is based in Nantgarw, UK. The British company operates like an early stage biotechnology company and applies focus and industry development expertise to efficiently translate discoveries to address viruses of concern. The company is unique in that it brings industry expertise to the assets of a leading research university to develop potential antiviral drugs to a de-risked value inflection point that substantially increases the probability of the potential drug being licensed by industry and developed for the ultimate benefit of the public. The company was founded in 1983. Rhian Jones has been the CEO of the company since 2018. | Commercial Services |
- Stock Market
- Insiders
- Rhian Jones
- Experience